SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001279569-16-003070
Filing Date
2016-03-31
Accepted
2016-03-30 18:04:16
Documents
8
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F v435656_20f.htm 20-F 1603722
2 EXHIBIT 4.29 v435656_ex4-29.htm EX-4.29 66257
3 EXHIBIT 12.1 v435656_ex12-1.htm EX-12.1 10134
4 EXHIBIT 12.2 v435656_ex12-2.htm EX-12.2 10021
5 EXHIBIT 13.1 v435656_ex13-1.htm EX-13.1 6178
6 EXHIBIT 23.1 v435656_ex23-1.htm EX-23.1 3746
7 GRAPHIC ex23-1tsig.jpg GRAPHIC 5725
8 GRAPHIC image_001.jpg GRAPHIC 2418
  Complete submission text file 0001279569-16-003070.txt   1712522
Mailing Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6
Business Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6 204-487-7412
MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 20-F | Act: 34 | File No.: 001-31995 | Film No.: 161541106
SIC: 2834 Pharmaceutical Preparations